Recent Press Releases

July 23, 2024

Frontier Medicines Announces Milestone Payment in AbbVie Partnership, Following Advancement of Lead Candidates Targeting a Historically Undruggable Transcription Factor

June 25, 2024

Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension

April 9, 2024

Frontier Medicines Presents New Data for First-In-Class Dual ON+OFF KRAS G12C Inhibitor FMC-376 at the AACR Annual Meeting


Events & Presentations
UPCOMING EVENTS

There are currently no upcoming events scheduled


Select Media Coverage

April 11, 2024

Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data

February 22, 2024

Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C

February 22, 2024

San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial

Media Center
Media Contact

Contact PR Team

Logos
Click on the links below to download a high resolution image of the Frontier Medicines logo